Events and Presentations

Part of the work at Abliva consists of making the company’s activities visible in different public contexts, partly to increase understanding of the enormous medical needs of people with primary mitochondrial disease, but also to increase interest in the company among potential investors or partners.

Company and project presentations

Abliva Company Presentation, July 2024 (pdf)Download

BioStock Life Science Summit
20 – 21 November 2024

Conference call on the positive interim analysis of FALCON
19 July 2024

BioStock Global Forum
29 – 30 May 2024

Abliva Virtual KOL Event
21 May 2024

BioStock Life Science Summit
25 – 26 October 2023

ABGSC Life Science Summit
30 – 31 May 2023

Penser Market Bolagsdag
25 May 2023

BioStock Investor Meeting
16 March 2023

Aktiespararna’s Stora Aktiedagen Stockholm
29 November 2022

Aktiespararna’s Aktiedagen Lund
26 September 2022

Aktiespararna’s Temadag Life Science
31 August 2022

© 2022 Oroboros Instruments

Bioblast 2022, Innsbruck, Austria
29 – 30 June 2022

BioStock interview on SEK 200 million financing round
June 1, 2022

Open the presentation here: Presentation Mitochondria-Targeted Drug Development

Mitochondria-Targeted Drug Development
22 – 24 Feb 2022.

For more of our videos, please visit our YouTube channel: